Biocracked
Approach: macro science. Palette: bold color field, a saturated teal backdrop.

Extreme close-up microscopy-style photograph of a thin slice of rat heart muscle on a glass slide, stained in rich magenta-pink with fine, wavy parallel muscle fibers. In one half of the frame the fibers are neat and orderly. In the other half, thick pale-blue-grey strands of fibrous scar tissue cut across them in a ragged band. The slide sits on a saturated teal surface and is shot from slightly above at a shallow angle, so the glass edge catches a crisp highlight. Soft, even studio light with a shallow depth of field blurs the slide's far corner. A single tiny electric green marker dot sits on the slide's edge. The mood is precise, investigative and slightly tense, with a vivid, graphic contrast between the teal and the magenta tissue. No text or labels.
Supplements

GlyNAC Shielded Diabetic Rat Hearts From Scarring—With One Catch

Nova Chen · · 4 min read

Read this first: This is a rat study of streptozotocin-induced diabetes and heart damage. It is not human evidence, and it does not show that glycine, NAC or any supplement protects people's hearts.

A glycine-plus-NAC combination, the same pairing behind the supplement trend known as GlyNAC, helped diabetic rats hold on to healthier heart tissue. But the researchers say the combo didn't win every round. NAC alone beat it on some measures.

The work comes from a team at the University of Sarajevo and Cantonal Hospital Zenica, published in Pathophysiology in 2026.

What the researchers actually tested

Diabetic cardiomyopathy is heart muscle damage driven by diabetes. It is linked to oxidative stress, inflammation and fibrosis, the stiffening, scar-like buildup of connective tissue. The team focused on the IL-33/sST2 signaling axis, which has emerged as a regulator of cardiac remodeling. Soluble ST2 (sST2) is a circulating marker tied to that process.

The design was simple:

  • 34 adult Wistar rats were split into five groups.
  • The groups were healthy controls, untreated diabetic rats, and diabetic rats given NAC (100 mg/kg/day), glycine (250 mg/kg/day), or both.
  • Diabetes was induced with a single injection of streptozotocin (55 mg/kg).
  • Treatment lasted 12 weeks.

The researchers measured serum sST2, IL-33, malondialdehyde (MDA, an oxidative-stress marker) and superoxide dismutase (SOD) activity. They also examined heart tissue with stereological and histopathological analyses.

The damage diabetes did

Untreated diabetic rats had significantly higher serum sST2, IL-33 and MDA. Their hearts showed marked remodeling:

  • expansion of the interstitial and perivascular compartments
  • increased connective tissue deposition
  • reduced cardiomyocyte volume density, meaning less of the heart was made of working muscle cells

In plain terms, the diabetic hearts were becoming more scarred and less muscular.

The striking finding: the combo and heart structure

Both NAC and glycine, given alone, significantly reduced these biochemical and structural abnormalities compared with untreated diabetic animals. The combination stood out on two fronts. It produced particularly pronounced reductions in sST2 and IL-33. It was also associated with preservation of myocardial architecture, the tissue-structure outcome closest to the scarring-type remodeling that defines the condition.

That is why the combination is the headline. On the structural and signaling measures the authors emphasize, the pairing looked especially favorable in these rats.

The catch: it wasn't a clean sweep

The authors explicitly avoid claiming the combo was better at everything. Treatment effects "varied across outcomes," and some oxidative-stress parameters improved more with NAC alone. The paper says its findings highlight potentially complementary actions of the two compounds "without implying uniform superiority of the combined regimen."

NAC is a precursor to cysteine, and glycine is the other building block of glutathione, so the two may play different roles. The paper frames this only as complementary actions, and it did not test a mechanism that explains the differences.

How this connects to human GlyNAC research

GlyNAC has drawn attention because human studies, mostly small ones in older adults and other specific groups, have explored whether it improves glutathione status and oxidative-stress markers. This rat paper is not part of that human evidence base. It adds a lab-animal signal in a different setting, diabetes-related heart remodeling. The authors describe it as "an experimental basis for further investigation," which is about as far as the data can go.

Why rat mg/kg doses don't translate to people

The doses above are rat doses, and you can't simply scale them to a human by body weight.

  • Rats and humans differ in metabolism, absorption and body-surface-area scaling.
  • The study used a chemically induced diabetes model that doesn't mirror the way type 2 diabetes develops in people.
  • It reports no human dosing, safety or long-term outcome data.

No human dose can be derived from this paper, and this article doesn't suggest one.

Practical takeaways

1. Treat it as a hypothesis. The study suggests glycine and NAC deserve further research in diabetic heart disease. It doesn't show they prevent or treat it in people.

2. Who might care. People with blood sugar issues, prediabetes or diabetes may be curious about GlyNAC. If that's you, talk to your doctor before adding supplements. Don't substitute them for prescribed diabetes or heart care.

3. NAC cautions. NAC can cause side effects such as nausea or other stomach upset in some people, and allergic-type reactions are possible. It can interact with certain medications, so check with a clinician or pharmacist, especially if you take heart medications, have asthma, are pregnant or breastfeeding, or have other medical conditions.

4. Don't overread small-animal data. This study used 34 rats. Whether the combined regimen's benefits hold up over time, in different models or in humans is unknown.

Bottom line

In diabetic rats, glycine plus NAC gave the strongest showing on sST2, IL-33 and preserving heart structure. NAC alone sometimes did better on oxidative-stress markers. That makes it an intriguing preclinical lead for GlyNAC, not a recommendation. Until controlled human studies test diabetic heart outcomes, the safest conclusion is that this is a promising rat finding that needs follow-up.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: conceptual metaphor. Palette: D, bold color field.

A saturated mustard-yellow backdrop fills the frame. Three clear glass beakers stand in a row on a matte surface, shot at eye level with a slightly low camera angle and a shallow depth of field. Each holds a different level of clear liquid (low, medium, high). The first two look identical and empty-seeming, while the third has a thin thread of vivid green liquid (#00e676) curling through it, a small accent against the yellow. Soft, large-source studio light comes from the left and casts crisp, short shadows onto the surface. Gentle highlights run along the glass rims, and tiny bubbles cling to the inner walls. The mood is quiet, curious and analytical, suggesting that a result shows up only for some. No text, labels or markings are visible.
longevity

The GlyNAC Trial That Didn't Raise Glutathione, Except in One Group

BY HELIX WARD ·

A 114-person randomized trial of GlyNAC, the glycine plus NAC combo pitched as an anti-aging glutathione booster, failed to raise glutathione in healthy older adults. Doses of 2.4, 4.8 and 7.2 g/day at a 1:1 ratio did nothing for the primary endpoint after two weeks. But a post-hoc subgroup with high oxidative stress and low baseline glutathione did see a rise at the medium and high doses. The Nestlé-run study raises a sharper question than whether GlyNAC works: for whom might it work? Here is what the trial showed, what it can't tell us, and how to read the responder signal.

A softly lit, minimalist still life on a pale oatmeal-colored linen surface, photographed from a slightly elevated three-quarter angle in a wide landscape frame. On the left, two small matte ceramic bowls in warm off-white and sage green hold fine white crystalline powder, one a little fuller than the other, with a few scattered grains catching the light. A slim brushed-brass measuring spoon rests beside them. In the center, a clear glass of water with a faint ripple, next to a small amber glass supplement bottle with a blank cream label and a few white capsules spilled onto the linen.

On the right, a sprig of fresh rosemary and a halved lemon add organic texture and a muted citrus yellow. A neat stack of two thick cream notebooks sits behind them, topped with a pair of thin round tortoiseshell reading glasses and a sharpened pencil. An open notebook page shows hand-drawn minimalist line charts, a simple upward curve and two small bar graphs, in soft graphite with no legible text.

Behind the arrangement, a blurred sunlit window casts long, gentle diagonal shadows across the surface, with sheer curtains diffusing the morning light. The background is a creamy neutral wall with a hint of a potted olive plant at the edge. The palette is warm and calm: ivory, sage, soft terracotta, pale gold, and touches of amber. Shallow depth of field keeps the bowls and bottle sharp while the background melts into soft bokeh. The mood is clean, editorial, and thoughtful, like a modern health and wellness magazine cover, with generous negative space in the upper left for a headline overlay. Subtle film grain, natural color grading, no people, no text, and no futuristic elements.
supplements

GlyNAC Trial: Glycine Plus NAC Reversed Multiple Aging Markers in Older Adults in 16 Weeks, but the Study Is Small

BY DR. SYNAPSE ·

A small randomized trial from Baylor College of Medicine found that 16 weeks of GlyNAC, a combination of glycine and N-acetylcysteine, corrected glutathione deficiency, oxidative stress, mitochondrial dysfunction and inflammation in older adults. Participants also improved on measures of physical function and several aging hallmarks, while a placebo did not. The protocol has used weight-based dosing of roughly 100 mg/kg of each amino acid, which is far above typical supplement doses. But with only 12 people per group and biomarker-focused outcomes, the results are promising rather than definitive. Here is what the study showed, what it means in practice, and where the caveats lie.

Approach: conceptual metaphor. Palette: bold color field (saturated orange).

A single clear glass of water sits on a seamless saturated tangerine-orange backdrop, shot from a low three-quarter angle at eye level. Dense streams of tiny hydrogen bubbles rise through the water, but at the surface the glass has cracked in a thin, sharp fracture line that runs up the side, as if the "healthy" promise has split. A few droplets hang mid-air beside the crack. Hard directional studio light from the upper left casts a crisp, elongated shadow across the orange floor, and bright caustic highlights bend through the water. A tiny electric green (#00e676) reflection glints along the rim of the glass. The look is clean, graphic and photorealistic, with shallow depth of field. The mood is skeptical and tense, with a quiet sense of irony.
supplements

Hydrogen Water Backfired: Oxidative Damage Marker Rose in Trial

BY HELIX WARD ·

Hydrogen-rich water is marketed as an easy antioxidant win, but a randomized, blinded trial in people with chronic mountain sickness found the opposite signal. After 8 weeks of 990 mL/day, the hydrogen group's MDA, a marker of oxidative damage, rose more than placebo's, by +2.11 (p < 0.001). Total antioxidant capacity rose too, and the MDA increase was larger in people with a BMI of 24 or higher. Adverse events were more common with hydrogen water (50% vs 37%), mostly dizziness. The study was small and specific to altitude patients, so here is what it does and doesn't mean for hydrogen water fans.

Approach: conceptual metaphor. Palette: warm.

A single ceramic mug on a wooden bedside table, filled with a pale, cloudy collagen drink, with a thin ribbon of steam rising from the surface. Camera angle is a low three-quarter view at table height, shallow depth of field. Behind the mug, a rumpled bed with crisp cotton sheets dissolves into soft bokeh. A small brass alarm clock stands beside it, its hands blurred and its face unreadable. Light comes from a warm amber bedside lamp, casting honey-gold highlights on the rim and long copper-toned shadows across the grain of the wood. Powder grains lie scattered on the table next to the mug, one tiny speck of electric green on the lamp's cord switch. The mood is quiet, drowsy and unhurried, the last calm minutes before sleep.
supplements

Is Your Collagen a Sleep Aid? Glycine Trials Say Maybe

BY NOVA CHEN ·

You bought collagen for your skin, but a new scoping review asks whether its glycine might also help you sleep. Glycine supplements reliably raise blood glycine, and all three glycine sleep trials found a benefit on at least one outcome. Collagen peptides showed fewer awakenings in one placebo-controlled trial and lower fatigue in another, yet failed to beat alpha-lactalbumin in head-to-head comparisons. Nobody has tested whether glycine is actually the mechanism. Here's the dose, the timing, and the limits you should know.

This page is available in